Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab + Chemo Neoadjuvant in LACC
NCT04799639Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2021
- Primary completion
- Jun 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in Cervical Cancer (CC), sponsored by Sun Yat-sen University. Started Mar 2021; status: completed.
02
Drugs
sintilimab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04799639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04799639.